The pathway is enriched with WW domain mediated interactions on the level of upstream modulators, core components, as well as downstream effectors (Figure 4) (1, 36, 37).The pathway is either inactivated or harbors a mutation in one of its components in many types of cancer; including breast cancer. This evidence concerns the gene ABCC11 and breast cancer.